机构:[1]Department of Hematology, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, China.[2]Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, China.[3]Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou, China.[4]Clinical Medicine, New York College of Traditional Chinese Medicine, Mineola, NY, United States.
第一作者机构:[1]Department of Hematology, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, China.
通讯作者:
推荐引用方式(GB/T 7714):
Lu Qisi,Wang Lihui,Zhang Jian-Ye,et al.Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II[J].Frontiers in oncology.2023,13:1164399.doi:10.3389/fonc.2023.1164399.
APA:
Lu Qisi,Wang Lihui,Zhang Jian-Ye&Yang Dong-Hua.(2023).Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II.Frontiers in oncology,13,
MLA:
Lu Qisi,et al."Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II".Frontiers in oncology 13.(2023):1164399